LONDON, Aug. 02, 2021 (GLOBE NEWSWIRE) — OKYO Pharma Limited (the “Company”) is pleased to announce its final audited results for the year ended 31 March 2021.
OKYO Pharma Limited (OKYO.L) Regulatory Development of OK-101 for Dry Eye Indications
London and Boston, MA, 29 June 2021 – OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory
Share Talk Weekly Stock Market News, 19th May 2019
It has been an interesting week across the markets as well lead up to the European elections here is the UK next week with sterling hitting a four year low.
Share Talk Bulletin Board Heroes, Friday 16th November 2018
A charting look at some of the most followed stocks on the London market, Zak Mir covers.